Comparison between Brooks Laboratories IPO and Inventure Growth IPO.
Brooks Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Inventure Growth IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Brooks Laboratories IPO is up to ₹63.00 Cr whereas the issue size of the Inventure Growth IPO is up to ₹81.90 Cr. The final issue price of Brooks Laboratories IPO is ₹100.00 per share and of Inventure Growth IPO is ₹117.00 per share.
| Brooks Laboratories IPO | Inventure Growth IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹90.00 per share | ₹100.00 per share |
| Issue Price (Upper) | ₹100.00 per share | ₹117.00 per share |
| Issue Price (Final) | ₹100.00 per share | ₹117.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | 50 shares |
| Fresh Issue Size | 63,00,000 shares | 70,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹63.00 Cr | up to ₹81.90 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 63,00,000 shares | 70,00,000 shares |
| Issue Size Total (Amount) | up to ₹63.00 Cr | up to ₹81.90 Cr |
Brooks Laboratories IPO opens on Aug 16, 2011, while Inventure Growth IPO opens on Jul 20, 2011. The closing date of Brooks Laboratories IPO and Inventure Growth IPO is Aug 18, 2011, and Jul 22, 2011, respectively.
| Brooks Laboratories IPO | Inventure Growth IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 16, 2011 | Jul 20, 2011 |
| Issue Close | Aug 18, 2011 | Jul 22, 2011 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 05, 2011 | Aug 04, 2011 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Brooks Laboratories IPO P/E ratio is , as compared to Inventure Growth IPO P/E ratio of .
| Brooks Laboratories IPO | Inventure Growth IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.5 | 72.02 | ||||
| Promoter Shareholding (Post-Issue) | 60.77 | 48.02 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹161.86 Cr. | ₹245.70 Cr. | ||||
| ROE | ||||||
| ROCE | 27.3 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 47.4 | 7.72 |
In the Brooks Laboratories IPO Retail Individual Investors (RII) are offered 22,05,000 shares while in Inventure Growth IPO retail investors are offered 22,05,000 shares. Qualified Institutional Buyers (QIB) are offered 31,50,000 shares in Brooks Laboratories IPO and 35,00,000 shares in Inventure Growth IPO.
| Brooks Laboratories IPO | Inventure Growth IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 31,50,000 shares | 35,00,000 shares |
| NII | 9,45,000 shares | 10,50,000 shares |
| RII | 22,05,000 shares | 24,50,000 shares |
| Employee | ||
| Others | ||
| Total | 63,00,000 shares | 70,00,000 shares |
Brooks Laboratories IPO subscribed 1.78x in total, whereas Inventure Growth IPO subscribed 4.58x.
| Brooks Laboratories IPO | Inventure Growth IPO | |
|---|---|---|
| QIB (times) | 0.00x | 0.25x |
| NII (times) | 3.13x | 9.49x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.73x | 8.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.78x | 4.58x |
